Free tool
FAERS Monitor: Opsumit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 204410 or its brand name (Opsumit, Macitentan). Reports on generic versions are filed under their own applications.
Reports
69,798
Serious
49,514
71% of reports
Hospitalization
34,460
Death reported
12,598
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea12,094
- headache8,458
- death7,416
- diarrhoea6,680
- nausea6,048
- fatigue5,154
- pneumonia4,605
- dizziness4,601
- hospitalisation4,147
- cough4,021
- fluid retention3,872
- hypotension3,677
- malaise3,624
- pulmonary arterial hypertension3,310
- vomiting3,220
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 41 |
| 2014 | 1,865 |
| 2015 | 4,343 |
| 2016 | 4,810 |
| 2017 | 5,403 |
| 2018 | 6,645 |
| 2019 | 7,435 |
| 2020 | 6,747 |
| 2021 | 5,158 |
| 2022 | 6,937 |
| 2023 | 6,556 |
| 2024 | 5,896 |
| 2025 | 5,096 |
| 2026 | 2,859 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,984,361 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pulmonary arterial hypertensionSignal | 3,310 | 88.9 | 85.6 | 222,091 |
| fluid retentionSignal | 3,872 | 24.7 | 24.0 | 81,699 |
| hospitalisationSignal | 4,147 | 8.3 | 8.1 | 26,214 |
| dyspnoeaSignal | 12,094 | 6.6 | 6.4 | 57,270 |
| hypotensionSignal | 3,677 | 5.6 | 5.4 | 13,795 |
| coughSignal | 4,021 | 4.4 | 4.2 | 10,432 |
| pneumoniaSignal | 4,605 | 4.3 | 4.2 | 11,819 |
| headacheSignal | 8,458 | 4.1 | 4.0 | 20,213 |
| diarrhoeaSignal | 6,680 | 3.1 | 3.1 | 9,948 |
| dizzinessSignal | 4,601 | 2.8 | 2.7 | 5,386 |
| deathSignal | 7,416 | 2.6 | 2.6 | 7,597 |
| malaiseSignal | 3,624 | 2.5 | 2.4 | 3,309 |
| nauseaSignal | 6,048 | 2.3 | 2.3 | 4,646 |
| vomitingSignal | 3,220 | 2.1 | 2.0 | 1,811 |
| fatigueSignal | 5,154 | 2.0 | 1.9 | 2,663 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.